Chris Murphy

A predicted 56,000 people will be employed in the fast-growing Medtech sector in Ireland, by 2028 - many of them in Regulatory Affairs, which will need to adapt for new areas such as smart devices and the AI Act, and market disruption from evolving MDR and IVDR directives and regulations. This Irish Medtech Springboard course accredited through Atlantic Technological University Galway and starting in January 2025, was developed to meet the urgent need for Regulatory Affairs professionals in the sector 🏭 ✅ 60 credit NFQ Level 8 award ✅ Unemployed, or those returning to work may be eligible to have fees covered in full (Free) ✅ Employed people or recent graduates receive a subsidy and pay just 10% of the course fees (€690) ✅ Places on Springboard+ and HCI courses are limited! Learn more and apply here: https://lnkd.in/efGphk8j Irish Medtech Jennifer Lynch #Funding #Training #HigherEducation #JobSeekers #Grants #CPD #Medtech #Upskilling

7

🔍 Delve into the future of MedTech with this compelling report from IDA Ireland! Discover how the industry is evolving and the pivotal role of digital transformation, innovation, and fostering a strong ecosystem for continued success. What strategies do you believe are crucial for MedTech companies to excel in the years ahead? #MedTech #Innovation #DigitalTransformation #DigitalHealth https://lnkd.in/ejyQsSQU

6

Today, we are launching our latest whitepaper ‘Where next for MedTech – Key considerations for the factory of the future’. The report outlines how Ireland has built its reputation as an exemplar for #MedTech advancement, offering an ecosystem that encompasses innovation, focuses on talent, and is committed to supporting client sustainability and digital transformation. One example of this is Digital Manufacturing Ireland (DMI), a newly launched national centre of excellence established by the Irish Government to assist Irish-based manufacturers in rapidly adopting digital technologies to transform their value chains.  “The global MedTech sector is absolutely committed to saving lives and enhancing patient’s quality of life. This demands a continuous focus on innovation, requiring companies not only keep pace with evolving patient needs but also new technologies. World leading companies need to be flexible and agile to adapt quickly to emerging global trends and challenges in order to remain competitive” - Rachel Shelly, Global Head of Life Sciences at IDA Ireland.   Read the full report here: https://lnkd.in/ejyQsSQU _ Thank you to everyone who contributed, including DePuy Synthes's Shane Maher and Colm Hynes, Bausch + Lomb's Mark Hennessy, Baxter International Inc.'s Seamus Maughan, DMI's Claude Costelloe, Domhnall Carroll and Michael Kiely, Baxter International Inc.'s James Jordan, Cook Medical's Emmett Devereux, Janssen's Gary Hartnett, Boston Scientific's 'Michael Murphy, and CERENOVUS's Michael Gilvarry. #InvestInIreland #InvestInExtraordinary #MedTech #FactoryoftheFuture

74

1 Comment

Ireland has been recognised globally as a #MedTech centre of excellence due to its strategic location, offering the essential stability, talent and ecosystem required to propel companies to the next level. Read the latest whitepaper launched by IDA Ireland which outlines how Ireland has built its reputation as an exemplar for #MedTech advancement. Fáilte Ireland Digital Manufacturing Ireland Rachel Shelly

4

Last Friday, we attended Medtech Rising 2024 for the second year in a row. Medtech Rising is the leading conference and awards ceremony for the Irish MedTech industry. The daytime event brought together 34+ speakers across 9 inspiring sessions, covering the hottest topics from across the #Medtech industry. Below are some of our key takeaways from the event: 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗥𝗲𝗳𝗼𝗿𝗺𝘀 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗘𝗨 𝗠𝗮𝗿𝗸𝗲𝘁 This panel discussion highlighted the need for simpler and streamlined EU regulatory frameworks. These reforms aim to lower costs, boost global competitiveness, and ensure patient access to cutting-edge devices. 𝗦𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗶𝗻 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 As expected, #sustainability took centre stage, with discussions around eco-conscious practices in product design, manufacturing, and supply chains. The challenge? Balancing environmental responsibility with regulatory and cost considerations. 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝘀 𝗶𝗻 𝗖𝗼𝗻𝗻𝗲𝗰𝘁𝗲𝗱 𝗛𝗲𝗮𝗹𝘁𝗵 Innovations in (Internet of Things)#IoT-driven healthcare, including real-time monitoring, diagnostics, and data analytics, are set to redefine patient care. These technologies promise improved outcomes and a revolution in healthcare delivery. 𝗗𝗶𝗴𝗶𝘁𝗶𝘀𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 #Digitisation was highlighted as vital to keeping Ireland competitive on the global MedTech stage. A strong focus was placed on adopting Industry 4.0 technologies, such as #robotics, #AI, and #automation, to enhance manufacturing efficiency. 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗜𝗿𝗲𝗹𝗮𝗻𝗱 Ireland remains a hub for medical device R&D, thanks to its vibrant ecosystem of startups, universities, and established companies. Collaborative efforts are fuelling the creation of next-generation technologies. 𝗪𝗼𝗿𝗸𝗳𝗼𝗿𝗰𝗲 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 Addressing skill gaps is essential to future-proofing the industry. Strong focus was placed on training and educational partnerships to ensure Ireland’s workforce can meet the demands of a digital and innovative Medtech landscape. The evening awards program was a great celebration of industry leaders. Although we didn’t take home the award this year, it was an incredible honour to be recognised alongside such outstanding companies. Congratulations to Freudenberg Medical for their well-deserved win in the Partner/Supplier of the Year Category! We’re grateful to Enterprise Ireland, IDA Ireland, and Irish Medtech for hosting such an impactful event. Excited to see what 2025 holds for the MedTech community! #MedtechRising2024 #MedTechInnovation #Awards #Networking

56

2 Comments

FIRE1 , a team of engineers, clinical trial specialists, and scientists has now implanted FIRE1's system into a patient in Ireland. FIRE1's system is a sensor implanted into the vena cava with a catheter and is meant to measure the fluid buildup in the body to warn against congestive heart failure! Their study FUTURE-HF will test the sensor's safety and efficacy in individuals with heart failure. They are seeking for implantation success and sensor functionality once implanted with this trial. They are also carrying out the FUTURE-HF2 trial which enrolled patients from the US starting last July. What an innovative device for heart failure! Learn more at the link below: https://hubs.li/Q02z8pCR0

2

Let's start the show. Medical Technology Ireland Expo and Conference. Comment below to book some time with one of our leaders. Medical Device Development Manufacturing. Everything In-House. #medtech #medicaldevice #conference #disruptors

6

Prolonged screen time and environmental factors are among the causes of dry eyes. This condition that affects the ocular surface can lead to symptoms such as discomfort, blurred vision, and a gritty or burning sensation. In an article in the Irish Independent, Mr. Ian Dooley, Consultant Ophthalmologist at Mater Private Network, discusses both non-invasive treatments and medical interventions for more severe cases that impact patients' quality of life. Read the full article, visit https://bit.ly/3Zri4b7

20

Steryl sets an industry benchmark in user ergonomics - extensive design iterations helped the team optimise grip and weight distribution, improving precision and manoeuvrability and reducing surgeon fatigue. Read more on the case here: https://lnkd.in/dE_EDVzD

70

1 Comment

Belfast company B-Secur, a leader in advanced biosensing technology, has announced the FDA clearance and launch of HeartKey® Rhythm, a suite of electrocardiogram (ECG) algorithms and analytics designed to enhance clinical confidence, streamline industry efficiency, and improve outcomes for cardiac patients.  Powered by B-Secur’s innovative signal processing engine, HeartKey Rhythm enhances signal clarity by reducing noise, delivering high-quality ECG data. Specifically targeted at the ambulatory ECG (AECG) market, HeartKey Rhythm’s rhythm detection algorithms and signal quality indicators allow clinicians to prioritize their interpretation of data and enable more confident detection of actionable cardiac conditions.   “Achieving FDA clearance for our latest product, HeartKey Rhythm, is a monumental step toward helping providers deliver more timely, efficient and preventative care,” said Alan Foreman, CEO and Co-founder of B-Secur. “This marks our second FDA clearance in just four years, highlighting our relentless drive for innovation and commitment to rapidly bringing impactful solutions to the market.  “One person dies every 33 seconds from cardiovascular disease (CVD) in the U.S., and by 2050, the total cost of CVD is expected to triple, reaching $1.851 trillion*. These figures are frankly alarming and underscore the urgent need for technological solutions that drive efficiencies and enable proactive monitoring.”  Alongside the two concurrent challenges of rising costs and an increasing prevalence of cardiovascular disease, the healthcare sector also faces another threat – a growing shortage of cardiologists and electrophysiologists. While ECG readings are foundational to cardiac diagnosis and care, they have traditionally been compromised by noise contamination, which limits their usability. Nearly 42% of healthcare professionals say that remote ECGs often require additional testing to confirm results, and 53% find these readings difficult to interpret.  “There is an ever-increasing reliance on ECG data collected outside of a controlled clinical environment,” said Adrian Condon, B-Secur’s CTO and Co-founder. In addition to ambulatory ECG devices (AECG), the rise of consumer wellness wearables, such as smartwatches and rings equipped with ECG capabilities, is generating an influx of data that device manufacturers can use to empower healthcare providers. However, the ability to keep pace with this volume depends on the accuracy and efficiency of ECG interpretation. While HeartKey Rhythm is focused on AECG, B-Secur also offers on-chip solutions designed for consumer wearable devices. B-Secur is backed by Orlando Health, a U.S. hospital and healthcare organization recognized by Fortune as one of America’s Most Innovative Companies in 2024.    Department for the Economy NI Department of Health NI Department for Science, Innovation and Technology Mike Nesbitt

8

Keeping on top of validation Nicky Varney (Steadman) explains how to make the most of your equipment engineer visit. Read the article here: ➡️ https://lnkd.in/eT3rgdKe #dentist #dentistry #equipment #maintenance #technology #technician

2

💡 Streamlining Cardiac Care with HRI ScanLink and ProLink 💡 At HRI, we’re dedicated to providing cutting-edge solutions for cardiac device management. Learn how HRI ScanLink (Device & Lead Barcode Scanning) and ProLink (Automated Follow-Up Data Capture) are helping physiologists streamline workflows, enhance efficiency, and meet MDR compliance standards. 🔑 Key Benefits Include: ✅ End-to-end traceability with Unique Device Identifiers (UDI) ✅ Improved accuracy and workflow efficiency ✅ Seamless, secure, and automated follow-up data transfer These tools are designed to support clinicians in delivering better patient care while staying ahead of regulatory requirements. 🌐 Visit our website or contact us to learn how HRI can transform your cardiac care workflows: https://lnkd.in/ecnpaK_B #CardiacCare #MedicalInnovation #HRI #EfficiencyInHealthcare

1

Episode six of The Leaders’ Room’s season two features Mag O Keeffe, VP, Global Additive Technologies at Stryker. In this episode, Mag speaks about her work at the medical technology giant, and the importance of leadership in creating environments where innovation can thrive. Stryker’s journey in Ireland began in 1998 with the establishment of its first operations in Carrigtwohill, Cork. With exponential growth across the eight dedicated sites in Ireland, the company now employs over 5,000 people directly. Stryker’s Irish R&D workforce contributes significantly to a diverse #MedTech portfolio, spanning from stroke care to hip implants, surgical instruments, and customised 3D-printed devices. You can listen to the full podcast here: https://lnkd.in/eFkQUDQc This series is created in partnership with Silicon Republic #InvestInIreland #InvestInExtraordinary

31

2 Comments

What do surgeons 𝗿𝗲𝗮𝗹𝗹𝘆 need from their instruments? Effective device design is critical in augmenting surgeons' capabilities, enabling them to perform life-saving work with greater precision, efficiency and ease. Steven McLellan, Senior Consultant - Design, explores the challenges and opportunities in surgical instrument design, drawing from 25 years of experience collaborating with surgeons.   𝗞𝗲𝘆 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀: • 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝘃𝗲 𝗱𝗲𝘀𝗶𝗴𝗻: partnering with surgeons is vital to address their priorities of efficiency, risk reduction and patient safety • 𝗛𝘂𝗺𝗮𝗻 𝗳𝗮𝗰𝘁𝗼𝗿𝘀: user studies reveal critical design requirements that can enhance usability, from ergonomics to reliability • 𝗙𝗼𝗿𝗺, 𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗳𝗮𝗺𝗶𝗹𝗶𝗮𝗿𝗶𝘁𝘆: aesthetic and intuitive designs help surgeons focus on their patients, not their tools   Read the full blog here: https://lnkd.in/eG4UVkcx

27